Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)

Wei Zhang,Pengbo Deng,Tiandong Kong,Bo Zhang,Fangfei Qian,Yu Dong,Ya Chen,Lu Chen,Danna Liu,Yanwei Zhang,Huaping Yang,Baohui Han

Lung Cancer（2022）

引用 5|浏览6

暂无评分

摘要

•Anlotinib combined with chemotherapy demonstrates the promising efficacy in ES-SCLC.•Anlotinib combined with chemotherapy was tolerable.•This is a multicenter, single arm, prospective study.

查看译文

关键词

Extensive stage small cell lung cancer,First-line treatment,Anlotinib,Chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要